Page last updated: 2024-10-25

cisapride and Flatulence

cisapride has been researched along with Flatulence in 3 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Flatulence: Production or presence of gas in the gastrointestinal tract which may be expelled through the anus.

Research Excerpts

ExcerptRelevanceReference
"The effects of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome (IBS) were evaluated in a randomized, double-blind, placebo-controlled study."9.07"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. ( Milo, R; Toussaint, J; Van Eeghem, P; Van Outryve, M, 1991)
"Cisapride has well-documented prokinetic effects and may be well suited for long-term therapy of GORD, but its effectiveness in purely symptomatic treatment is unknown."6.68The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. ( Carling, L; Hatlebakk, JG; Johnsson, F; Thøgersen, T; Vilien, M; Wetterhus, S, 1997)
"The effects of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome (IBS) were evaluated in a randomized, double-blind, placebo-controlled study."5.07"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. ( Milo, R; Toussaint, J; Van Eeghem, P; Van Outryve, M, 1991)
"Cisapride has well-documented prokinetic effects and may be well suited for long-term therapy of GORD, but its effectiveness in purely symptomatic treatment is unknown."2.68The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. ( Carling, L; Hatlebakk, JG; Johnsson, F; Thøgersen, T; Vilien, M; Wetterhus, S, 1997)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatlebakk, JG1
Johnsson, F1
Vilien, M1
Carling, L1
Wetterhus, S1
Thøgersen, T1
Raedsch, R1
Van Outryve, M1
Milo, R1
Toussaint, J1
Van Eeghem, P1

Reviews

1 review available for cisapride and Flatulence

ArticleYear
[Meteorism and flatulence].
    Medizinische Monatsschrift fur Pharmazeuten, 1992, Volume: 15, Issue:12

    Topics: Cisapride; Colonic Diseases, Functional; Combined Modality Therapy; Flatulence; Gases; Humans; Intes

1992

Trials

2 trials available for cisapride and Flatulence

ArticleYear
The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:11

    Topics: Abdominal Pain; Cisapride; Constipation; Diarrhea; Drug Administration Schedule; Endoscopy; Esophagi

1997
"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride.
    Journal of clinical gastroenterology, 1991, Volume: 13, Issue:1

    Topics: Abdominal Pain; Adolescent; Adult; Aged; Cisapride; Colonic Diseases, Functional; Constipation; Defe

1991